AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2013
Jun 27, 2013
31046_dirs_2013-06-27_e3e275da-ba2f-44a7-a65a-2b544d2e1184.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2013-05-15
Reporting Person: Rothera Mark (Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-06-25 | Common Stock | P | 25000 | $15.00 | Acquired | 25000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-15 | Stock Option (right to buy) | $10.85 | P | 15000 | Acquired | 2023-05-15 | Common Stock (15000) | Direct |
| 2013-05-15 | Stock Option (right to buy) | $10.85 | P | 150000 | Acquired | 2023-05-15 | Common Stock (150000) | Direct |
Footnotes
F1: This option was granted on May 15, 2013 and vests over four years, subject to achievement of specified performance objectives, with 25% of the shares underlying the option vesting on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
F2: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vesting on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 30, 2014.